The purpose of this study was to demonstrate the anti-inflammatory effects of L-mimosine on chronic inflammation, by investigating its effect on the immunological response of BALB/c mice infected with the nematode parasite Trichinella spiralis. Specific anti-parasite immunoglobulins (IgG, IgG 1 and IgM) were detected by the ELISA method in the serum of both the treated and the untreated animals at different periods of time for 60 days post infection. Two groups consisting of 18 mice each were used. The mice were 6 weeks of age. Both groups were infected with 220 larvae (L1 -T. spiralis) per os: one group was administered an intraperitoneal injection of L-mimosine (200 f.LgllOO ml/dose) for 27 days (the first injection started 7 days before infection) and the second group was administered an intraperitoneal injection of saline solution (100 p.l/dose).
appearance of antigens evoke serum antibodies late during the intestinal phase ofthe infection and other antigens are produced from larvaeestablished in the muscle that evoke antibodies much later in infection. B cells are activated from 3-13 days after the infection and high amounts of IgG I' IgG z ' IgM, and IgA are produced 2-6 weeks later (5) .
The compound L-mimosine, which is a plant amino acid, [beta-N (3-hydroxy-4-pyridone)-alphaamino propionic acid] has'been reported to block cell cycle progression and DNA replication in cultured mammalian cells and inhibits cytoplasmatic serine hydromethyltransferase (SHMT) transcription by chelating iron (6) (7) . L-mimosine also arrests cell cycle progression .at the G1-S phase border (8) , while persistent DNA damage inhibits S-phase and G, progression and results in apoptosis (9) . In addition, L-minosine inhibits the DNA synthesis in a variety of DNA viruses, including adenovirus, parvovirus and the replication of vaccinia and herpes simplex virus-l in cell cultures (10) . Moreover, L-mimosine completely prevents the uptake of 3H-thymidine into DNA when added to cells in S-phase and also prevents the formation or replication forks in the dihydrofolate reductase origin in some cells by inhibiting deoxyribonucleotide metabolism (11).
To study the mechanism by which Lmimosine sustains immunofunction, we treated mice with L-mimosine, a potent inhibitory compound of serine-hydromethyltransferase (SHMT), which is a vitamin B 6-dependentenzyme and influences immunological parameters. Lmimosine exerts its effect at the enzyme level by antagonizing the coenzyme PLP (phosphate pyridoxal) in an equimolar manner (12) .
In our study, 36 BALB/c mice infected with T. spiralis were treated with intraperitoneal (i.p.) injections of L-mimosine or saline solution and the serum antibodies IgG, IgG 1 , and IgM, as well as the response to the infective larvae, the intestinal worms and the newborn larvae, were studied.
MATERIALS AND METHODS

Animals -Experimental Protocol
Thirty-six BALB/c mice (S. Morini, S. Polo D' Enza (RE Italy), raised in the same environmental conditions, were used. On the day of infection, the animals were given per os, after a one-day fast, a single dose of220 Ll-T. spiralis. Briefly, T. spira(is parasites were maintained by continuous passages through BALBI c mice. Infected mice were sacrificed and encysted L 1-T. spiralis to the diaphragmatic tissue (or to the muscle of the right and left masseters), were counted by trichinoscopy (x 50 enlargement). The 36 mice were divided into two groups of 18 mice each and treated as follows. Group I: i.p, administration of200 flgII 00 fll/ dose (12) of L-mimosine (cat.nu.M0253, Sigma Chimica, Div. Sigma-Aldrich, S.r.l. Milano, Italy). Group 2: i.p. administration of saline solution (100 u.l/dose).
Additionally, 18 non-infected mice (3ld group) were used as controls, receiving only L-mimosine and, also, 18 healthy mice (4 th group) were used as negative controls. The treatment with the compounds L-mimosine and saline started seven days before infection and continued for 21 consecutive days p.i.. Both groups were maintained on this regimen for 60 consecutive days p.i ..
T. spiralis antigen
Excretory-secretory (ES) antigen prepared from T. spiralis muscle larvae (13) was kindly supplied to our laboratory by the National Institute of Public Health, Parasitology Dept., The Netherlands.
Detection of T. spiralis IgG. IgG J • IgM
Blood samples (100 _l/mouse) were drawn from an ocular vein and collected in a disposable syringe on days I, 10, 20, 30, 40, 50 and 60 p.i. Specific immunoglobulins were detected by ELISA, as previously described (3) . Briefly, ELISA plates were coated with 100 fll of soluble Ll-T. spiralis antigen (10 u.g/ml in carbonate buffer pH 9.6) and incubated at 24°C for 14h. After washing the plates with saline containing 0.05% Tween-20 (P1379 Sigma Chern, MO, USA) 100 fll of serum (L 100 dilution in PBS) was added per well. The plates were incubated, washed and developed with the appropriate conjugate (AA272, AA273 and AA278 "The binding Site" Ltd., Birmingham, England) using 0.1 mg of substrate, p-nitrophenyl phosphate (104.0, Sigma) in 100 fll of carbonate buffer containing I mM MgCI 2 , pH 9.8. The absorbance was measured on a TOYO ETY-III Analyzer (TOYO Oriental Instrument Ltd., Tokyo, Japan) operating with a 630 nm reference and a 405 nm (A/405 nm) measurement filter.
Number ofLI -T. spiralis cysts in the diaphragm of mice treated or not with L-Mimosine
The encysted larvae of T. spiralis present in the diaphragm from infected mice treated with L-mimosine were estimated on days 10, 20, 30, 40, 50 and 60 after infection, counting the cysts by trichinoscopy (x 50 magnification). Every week three mice from each group were sacrificed, by inhalation of CO z , and decapitated to estimate of number of cysts. The diaphragmatic tissue was surgically isolated and after washing the saline, was placed on a glass slide under a microscope.
Histological study
Conventionalmethodswere used for histopathology. Tissue specimens of the diaphragm were fixed in 10% buffered formalin, embedded in paraffin, sectioned at 5 IJ.m. and stained with hematoxylin and eosin .
RESULTS
The mice were di vided into four groups: group I and 2 were mice infected with 220 L I larvae of T. spiralis and treated intraperitoneally with Lmimosine (200 J.l.g/ I00 p.l/dose) or saline solution (100 p.l/dose). Group 3 and 4 were non-infected mice treated with L-mimosine or saline . The IgM, IgG and IgG I serum levels detected in the mice of group 3 and 4 were very low at all days studied (from 10-60 day s) , compared to mice infected with T. spiralis (group I and 2).
Number of cysts induced by LI-T. spiralis in th e diaphragm of treated (L-Mimo sine) and untreated (salin e) mice
In order to calculate the number of cysts in the diaphragm of Ll-T. spiralis infected mice, the diaphragm was removed from the dead animal and analyzed. In Tab . I we show the number of encysted larvae in the diaphragm after T. spiralis infection in mice treated and not treated with Lmimosine . Animals treated with L-mimosine inhibited the recruitment oflarvae in the diaphragm when compared to the untreated mice. The numbers represent the mean ± S.D. of the number of cysts per animal in 18 animals per group. In animals with intraperitoneally administration ofL-mimosine the number of cysts were drastically reduced from days 10-60 (Tab. I) .
T. spiralis infected striated muscle fiber of mice
In order to demonstrate that the mice were indeed infected with T. spiralis, histological studies were performed to confirm the infection. Fig. 2 shows the IgM levels at different days post-infection detected in serum of mice infected and treated i.p, with L-mimosine or saline. In mice treated with saline IgM level increases at day 10 (l220±171 pg/ml), reaching a peak on day 20 (l538±122 pg/ml), and then declines on day 30 (1344±165 pg/ml). A second peaking, higher than the first, was observed on day 40 (l680±139 pg/ ml). After this day it rapidly declines to reach a minimum on day 60 (1111±207 pg/ml). Meanwhile, in mice treated with L-mimosine the IgM level was significantly lower. In fact, it was first detectable on day 20 (360±95 pg/ml) and peaked at day 40 (999±104 pg/ml). After this day the level declined and it was totally undetected at day 60. Fig. 3 shows the serum levels ofIgG during T. spiralis infection. Mice were infected per os with 220 Lllarvae of T. spiralis (dayl), and treated or not with the anti-inflammatory compound Lmimosine. In infected mice not treated with Lmimosine the IgG level was significantly higher at all days studied. IgG level was detected as early as day 10 p.i. (560±99 pg/ml). From 20 th to 60 th day IgG level ranged between 1044±166 pg/ml at day 20 and 2088±21O pg/ml at day 60. In mice treated with L-mimosine values were much lower. We show that L-mimosine inhibited the release of serum IgG in the first 2 weeks p.i. IgG was detected at day 20 p.i, (252±148 pg/ml) remained stable until the 30 th day (351±53 pg/ml), reaching a maximum effect at 50 th day (l220±19l pg/ml). Fig. 4 illustrates that mice infected with T. spiralis, treated or not with L-mimosine, produced increased levels of IgG 1 10 days (291±93 pg/ml) p.i.; the level was 333±100 pg/ml and 510±91 pg/ ml on the 20 th and 30 th day, respectively. The first peak was observed at day 40 (698±8l pg/ml), and then decreased at day 50 (635±78 pg/ml); a second, similar peak was obtained on day 60 (753±75 pg/ ml). When mice were treated with L-mimosine (second group) the first detection of IgG I serum level observed at 30 day p.i. (l41±37 pg/ml) and the maximum increase was found at day 40 (300±48 pg/ml) and then progressively decreased to plateau (l85±60 pg/ml and l70±40 pg/ml at day 50 and 60). This figure clearly shows that the level of IgG I in non-treated mice is much higher (698±81 pg/ml at day 30) than the IgG 1 of L-mimosine treated mice (300±48 pg/ml at day 30).
Generation ofIgM in T. spiralis infected mice treated and not treated with L-Mimosine
IgG generation in L-Mimosine treated mice
Determination of Ig'G, in the Serum of Mice Treated with L-Mimosine
DISCUSSION
Different antibodies and cell types mediate of T. spiralis cell cycle in the various phases (3, 5, (14) (15) (16) . Th2 subset, which controls these responses with the production of cytokines, is induced after recognition of L 1-T. spiralis epitopes in the mesenteric lymph nodes, meanwhile Th 1 are induced by recognition of epitopes in the spleen (17) (18) (19) . The increase of IgM and IgG at day 20 p.i, reflect the dynamic of the antigen during the life cycle of the parasite. The infective larva in the intestine of the mice becomes adult in 36h after infection and the period from 5-15 days p.i, corresponds to the production and migration of the new born L1 larvae to the muscle (20) (21) (22) (23) (24) . B cells are stimulated to produce IgG and IgM after recognition of epitopes of the hypodermis, the intestinal gland cell granules, or others, of the T. spiralis L 1 larvae between the 3 rd and 13 th day p.i. and are detected 2-6 weeks after infection (25) (26) (27) . IgG I indicates specificity for the stichocyte granules and the cuticle of the parasite (28) and are usually detectable 15-32 days p.i. (5) .
In this study the effect of L-mimosine in mice infected with the nematode parasite T. spiralis was studied by analyzing the antibody response against T. spiralis infection. There was observed a slackening and weaker immunological response ofIgG, IgM and IgG 1 , antibodies in mice infected with T. spiralis and treated with L-mimosine compared with the same antibodies in not-treated infected mice. This effect may be due to a decreased frequency of antibodies-secreting B lymphocyte clones and also since T-helper lymphocytes from L-mimosine treated mice fail to provide a B-cell stimulus for antigen specific antibodies response (26) .
Our results showed that parasite burdens were affected by L-mimosine status. In fact in mice treated with L-mimosine there was a significant decrease in the number of cysts present to the diaphragm and also an inhibition effect of the recruitment of the white blood cells including neutrophils, macrophages (M0s) and lymphocytes was observed (Fig. 1) . One possible explanation is ' that the larvae, which rapidly develops following infection contains a large population of cells ready to synthesize DNA. In this stage L-mimosine, an important enzyme for cell proliferation and immune response, inhibits DNA synthesis at the level of elongation of nascent chains, by altering deoxyribonucleotide metabolism (11), or by blocking SHMT, which plays a vital role because it is the key enzyme for DNA and RNA synthesis and through this may arrest cell proliferation in phase S of the cell cycle (12) .
Recent evidence shows that in Trichinella spiralis-infected mice there is a strong immune response, as measured by induction of serum antibody, activation of peritoneal mast cells, CD8+ and CD4+ T-cells and cytokines (29) (30) (31) . IFN'Y, IL-4 and IL-5 reciprocally regulate the production of immunoglobulin isotypes. Some authors suggested that Th 1 activation may be associated with resistance to helminth infection (17, 32) . Resistance to T. spiralis infection is associated with a rapid expulsion of adult worms that can be induced by production of specific antibody (33) , by activation of inflammatory cells and mediators (34), by differential induction ofT-cell subsets (4) and by lymphokine production (35) .
In other experiments TNFex, IL-6, IL-4 and IFN'Y strongly augmented after the infection with the nematode T. spiralis, while IL-l 0 was generated in small amounts compared to the other cytokine production (17, 36) . The highest serum levels of each of these cytokines were reached at different periods of time during the infection. The peak for 1FN'Y and TNFex was at 35 days p.i., while for IL-4 and IL-6 was observed at days 21 and 7, respectively. When infected mice were treated with L-mimosine, strong inhibition of TNFex and IL-6 generation (unpublished results) may be induced, by changing the pattern of cytokine and immunoglobulin secretion during T. spiralis infection (37) (38) , thereby altering in immune response to parasite antigens with profound immunological consequences (39-45) may be observed. Our work describes an additional biological activity of L-mimosine and shows for the first time that mice treated with L-mimosine demonstrate strongly inhibitory effects on inflammation due to the T. spiralis response.
